The Roles of Maternal Depression Serotonin Reuptake Inhibitor Treatment and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month

摘要

ObjectiveThe purpose of this article was to systematically compare the developmental trajectory of neurobehavior over the first postnatal month for infants with prenatal exposure to pharmacologically untreated maternal depression, selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors (collectively: SSRIs), SSRIs with concomitant benzodiazepines (SSRI plus benzodiazepine), and no maternal depression or drug treatment (no exposure).